NCT02860299View on ClinicalTrials.gov

Biological and Clinical Measurements Following Systemic Leakage When a Citrate or Heparin Lock is Used

PHASE4CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

February 28, 2015

Primary Completion Date

January 31, 2016

Conditions

Acute Renal Insufficiency

Interventions

DRUG

citrate 4%

DRUG

unfractionated heparin

BIOLOGICAL

blood sample

Trial Locations (1)

21079

CHU Dijon Bourgogne, Dijon

All Listed Sponsors

lead

Centre Hospitalier Universitaire Dijon

OTHER

NCT02860299 - Biological and Clinical Measurements Following Systemic Leakage When a Citrate or Heparin Lock is Used | Biotech Hunter | Biotech Hunter